| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥4247.4B | ¥4134.3B | +2.7% |
| Operating Income | ¥-46.7B | ¥97.5B | +2.5% |
| Ordinary Income | ¥-49.6B | ¥59.2B | -35.3% |
| Net Income | ¥-62.6B | ¥55.2B | -9.5% |
| ROE | -3.4% | 2.8% | - |
FY2026 Q3 consolidated results show revenue of 424.7B yen (YoY +2.7%), but profitability deteriorated significantly with operating loss of -4.7B yen (prior year +9.7B yen), ordinary loss of -5.0B yen (prior year +5.9B yen, YoY -35.3%), and net loss of -6.3B yen (prior year +5.5B yen). The company shifted from profitability to loss despite revenue growth, primarily due to low gross margin of 16.2% and selling, general and administrative expenses of 73.6B yen exceeding gross profit. Non-operating expenses included foreign exchange losses of 2.9B yen and interest expenses, while special losses featured impairment charges of 1.6B yen. Total assets increased to 655.2B yen from 609.7B yen, while total equity decreased to 186.9B yen from 198.0B yen, reflecting the cumulative impact of net losses and elevated financial leverage.
[Profitability] ROE of -3.4% represents a significant decline from positive territory in the prior year, with operating margin of -1.1% and net profit margin of -1.5% indicating fundamental profitability challenges. Gross profit margin of 16.2% falls substantially below manufacturing industry standards, while EBIT margin of -1.1% reflects operating-level losses. The DuPont decomposition shows ROE driven by negative net profit margin of -1.5%, asset turnover of 0.648, and financial leverage of 3.51x, with the profit margin deterioration being the primary driver of negative returns. [Cash Quality] Cash and deposits of 68.8B yen provide coverage of 0.89x against short-term borrowings of 77.2B yen, indicating limited liquidity cushion. Working capital efficiency shows concerning trends with days sales outstanding of 199 days and cash conversion cycle of 194 days, reflecting significant cash collection delays. [Investment Efficiency] Total asset turnover of 0.648 compares to industry median of 0.58, indicating relatively efficient asset utilization despite profitability challenges. Return on assets of -1.0% and return on invested capital reflect the impact of operating losses on capital efficiency. [Financial Health] Equity ratio of 28.5% is substantially below the industry median of 63.8%, while debt-to-equity ratio of 2.51 indicates elevated financial leverage. Current ratio of 105.6% and quick ratio of 104.7% barely exceed 100%, with short-term debt representing 53.1% of total liabilities. Interest coverage ratio of -4.50x reflects negative EBIT relative to interest expenses of 1.0B yen, signaling debt servicing concerns.
Cash and deposits decreased to 68.8B yen with limited disclosure of detailed cash flow statement data for the quarterly period. Balance sheet analysis reveals significant working capital pressures, with accounts receivable of 232.1B yen representing 35.4% of total assets and indicating extended collection periods. Short-term borrowings increased sharply by 40.8B yen or 112.0% from 36.4B yen to 77.2B yen, suggesting increased reliance on short-term financing to fund operations. Inventory rose by 1.1B yen or 55.1% to 3.2B yen, with work-in-process inventory of 18.9B yen indicating production process accumulation. Accounts payable decreased by 14.8B yen or 26.0% from 56.9B yen to 42.1B yen, potentially reflecting shortened payment terms and increased cash outflow pressure. The cash-to-short-term debt ratio of 0.89x combined with the 53.1% short-term liability concentration indicates refinancing risk. Contract liabilities of 82.8B yen represent advance customer payments, providing some working capital support, though the overall liquidity position warrants close monitoring given the negative operating performance and elevated receivables balance.
Ordinary loss of -5.0B yen versus operating loss of -4.7B yen indicates net non-operating expenses of approximately 0.3B yen. Non-operating income totaled 5.1B yen including interest and dividend income, while non-operating expenses of 5.4B yen comprised interest expenses of 1.0B yen and foreign exchange losses of 2.9B yen. Special items showed special gains of 2.9B yen offset by special losses of 3.2B yen including impairment losses of 1.6B yen. One-time items representing approximately 25.5% of the net loss magnitude raise concerns about earnings sustainability. The absence of detailed operating cash flow data limits direct assessment of cash-backed earnings quality, though the elevated receivables balance of 232.1B yen with 199-day collection period suggests significant accruals. The effective tax rate of 77.0% appears elevated, though loss positions complicate standard tax analysis. Revenue growth of 2.7% contrasts sharply with operating loss, indicating margin compression rather than revenue quality issues. The combination of low gross margin at 16.2%, SG&A expenses exceeding gross profit, and substantial one-time charges indicates earnings quality concerns centered on operational execution rather than accounting treatments.
Liquidity and refinancing risk: Short-term borrowings surged 112.0% to 77.2B yen with cash coverage of only 0.89x, while short-term liabilities represent 53.1% of total liabilities at 362.3B yen. The combination of negative operating performance, extended receivables collection (DSO 199 days), and concentrated near-term debt maturity creates material refinancing pressure.
Working capital deterioration: Accounts receivable of 232.1B yen represents 35.4% of total assets with collection period of 199 days, substantially exceeding the industry median of 83 days. Cash conversion cycle of 194 days reflects inefficient working capital management, tying up significant operating cash and contributing to short-term borrowing dependency.
Structural profitability challenges: Gross margin of 16.2% combined with SG&A expenses of 73.6B yen creates negative operating leverage where revenue growth does not translate to profit improvement. Operating margin of -1.1% versus industry median of 8.3% and the shift from 9.7B yen operating profit to -4.7B yen loss indicates fundamental business model stress requiring operational restructuring.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of -1.1% significantly underperforms the manufacturing industry median of 8.3% (IQR: 4.8%-12.6%, n=98). Net profit margin of -1.5% compares unfavorably to industry median of 6.3% (IQR: 3.2%-9.0%, n=98). ROE of -3.4% falls well below the industry median of 5.0% (IQR: 2.9%-8.1%, n=98), placing the company in the bottom quartile for profitability metrics.
Financial Health: Equity ratio of 28.5% is substantially below the industry median of 63.8% (IQR: 49.5%-74.7%, n=98), indicating elevated financial leverage relative to peers. Current ratio of 105.6% falls significantly short of the industry median of 2.84x (IQR: 2.10x-3.81x, n=81), reflecting constrained liquidity. Financial leverage of 3.51x exceeds the industry median of 1.53x (IQR: 1.31-1.85, n=98), confirming above-average debt reliance.
Efficiency: Asset turnover of 0.648 slightly exceeds the industry median of 0.58 (IQR: 0.42-0.66, n=98), indicating relatively efficient asset utilization. However, receivables turnover of 199 days materially exceeds the industry median of 83 days (IQR: 68-115 days, n=97), highlighting collection inefficiency. Operating working capital turnover substantially lags industry standards, contributing to cash conversion challenges.
Growth: Revenue growth of 2.7% aligns with the industry median of 2.7% (IQR: -1.9%-7.9%, n=98), though the combination with negative profitability indicates margin compression unique to the company rather than sector-wide trends.
※ Industry: Manufacturing sector (98 companies), Comparison: FY2025 Q3 period, Source: Proprietary analysis
Margin recovery imperative versus revenue growth: Revenue increased 2.7% in line with industry median performance, yet the company uniquely deteriorated from operating profit of 9.7B yen to operating loss of -4.7B yen. This divergence from sector peers, where median operating margin remains healthy at 8.3%, indicates company-specific execution challenges. The 16.2% gross margin substantially lags industry standards, requiring urgent product mix optimization, pricing discipline, or cost structure realignment. Management's full-year guidance projects operating income recovery to 13.5B yen, implying Q4 contribution exceeding 18.0B yen, necessitating verification of underlying improvement drivers including receivables collection acceleration and one-time cost reversals.
Working capital optimization critical for liquidity stabilization: The 199-day receivables collection period more than doubles the 83-day industry median, representing approximately 149B yen in excess working capital tied up relative to industry-standard collection velocity. This inefficiency directly contributes to the 112% surge in short-term borrowings to 77.2B yen. The 194-day cash conversion cycle severely constrains cash generation despite revenue growth, while the simultaneous 26% reduction in payables suggests potential supplier credit tightening. Near-term cash flow improvement depends critically on receivables acceleration, with each 30-day DSO reduction potentially releasing approximately 28B yen in operating cash. The negative operating performance combined with 0.89x cash coverage of short-term debt elevates refinancing risk, making Q4 working capital execution a key monitoring priority.
Financial structure vulnerabilities amplified by profitability pressure: The 28.5% equity ratio and 2.51x debt-to-equity ratio position the company in the bottom quartile for manufacturing sector financial health, where industry median equity ratio stands at 63.8%. Negative interest coverage of -4.50x with 1.0B yen annual interest expense creates debt servicing vulnerability if operating losses persist. The 53.1% short-term liability concentration intensifies refinancing sensitivity to lender confidence and working capital performance. While the company maintains a 25 yen dividend commitment, the -67.4% payout ratio against net loss raises sustainability questions absent confirmed positive operating cash flow. Deleveraging path depends on both operational turnaround to restore cash generation and potential refinancing of short-term debt into longer-maturity structures to reduce rollover risk.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.